Animal Models in Cardiovascular Research: Hypertension and Atherosclerosis

BioMed Research International

Volumn 2015, Issue , 2015, Pages

  Leong, Xin Fang ^a,b   Ng, Chun Yi ^a   Jaarin, Kamsiah ^a  

^a UNIVERSITI KEBANGSAAN MALAYSIA MEDICAL CENTER   (Malaysia)

^b UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL MODEL; ATHEROGENESIS; CANINE MODEL; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR SYSTEM; CHICKEN MODEL; DRUG SAFETY; EXPERIMENTAL ATHEROSCLEROSIS; EXPERIMENTAL HYPERTENSION; EXPERIMENTAL MODEL; FEASIBILITY STUDY; GUINEA PIG MODEL; HAMSTER MODEL; HUMAN; MOUSE MODEL; NONHUMAN; PIGEON; PORCINE MODEL; PRIMATE MODEL; RABBIT MODEL; RAT MODEL; REVIEW; ANIMAL; ATHEROSCLEROSIS; DISEASE MODEL; GENETICS; HYPERTENSION; PATHOPHYSIOLOGY;

ANIMALIA;

ANIMALS; ATHEROSCLEROSIS; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION;

EID: 84929630420     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2015/528757     Document Type: Review

References (135)

1. https://www.gov.uk/government/statistics/statistics-of-scientific-procedures-on-living-animals-great-britain-2013.
2. T. B. Franklin, H. Russig, I. C. Weiss et al., "Epigenetic transmission of the impact of early stress across generations," Biological Psychiatry, vol. 68, no. 5, pp. 408-415, 2010.
3. Z. T. Erickson, E. A. Falkenberg, and G. A. S. Metz, "Lifespan psychomotor behaviour profiles of multigenerational prenatal stress and artificial food dye effects in rats," PLoS ONE, vol. 9, no. 6, Article ID e92132, 2014.
4. The Chimpanzee Sequencing and Analysis Consortium, "Initial sequence of the chimpanzee genome and comparison with the human genome," Nature, vol. 437, no. 7055, pp. 69-87, 2005.
5. R.J. Mural, M.D. Adams, E.W. Myers et al., "A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome," Science, vol. 296, no.5573, pp.1661-1671,2004.
6. B. G. Katzung, S. Masters, and A. Trevor, Basic and Clinical Pharmacology, Appleton & Lange, Norwalk, Conn, USA, 12th edition, 2012.
7. W. M. S. Russell and R. L. Burch, The Principles of Humane Experimental Technique, London, UK, Methuen, 1959, http://altweb.jhsph.edu/pubs/books/humane exp/het-toc#.
8. M. Emerson, "Refinement, reduction and replacement approaches to in vivo cardiovascular research," British Journal of Pharmacology, vol. 161, no. 4, pp. 749-754, 2010.
9. C. Kilkenny, W. Browne, I. C. Cuthill, M. Emerson, and D. G. Altman, "Animal research: reporting in vivo experiments: the ARRIVE guidelines," British Journal of Pharmacology, vol. 160, no.7,pp.1577-1579,2010.
10. C. R. Hooijmans, M. Leenaars, and M. Ritskes-Hoitinga, "A gold standard publication checklist to improve the quality of animal studies, to fully integrate the three Rs, and to make systematic reviews more feasible," Alternatives to Laboratory Animals, vol. 38, no. 2, pp. 167-182, 2010.
11. S. M. Williams, J. L. Haines, and J. H. Moore, "The use of animal models in the study of complex disease: all else is never equal or why do so many human studies fail to replicate animal findings?" BioEssays, vol. 26, no. 2, pp. 170-179, 2004.
12. H. B. van der Worp, D. W. Howells, E. S. Sena et al., "Can animal models of disease reliably inform human studies?" PLoS Medicine, vol. 7, no. 3, Article ID e1000245, 2010.
13. R. Greek and A. Menache, "Systematic reviews of animal models: methodology versus epistemology," International Journal of Medical Sciences, vol. 10, no. 3, pp. 206-221, 2013.
14. J. Hau, "Animal models for human diseases," in Sourcebook of Models for Biomedical Research, P. M. Conn, Ed., pp. 3-8, Humana Press, Totowa, NJ, USA, 2008.
15. M. B. Bracken, "Why animal studies are often poor predictors of human reactions to exposure," Journal of the Royal Society of Medicine, vol. 102, no. 3, pp. 120-122, 2009.
16. L. E. Mignini and K. S. Khan, "Methodological quality of systematic reviews of animal studies: a survey of reviews of basic research," BMC Medical Research Methodology, vol. 6, article 10, 2006.
17. E. S. Sena, C. L. Briscoe, D. W. Howells, G. A. Donnan, P. A. G. Sandercock, and M. R. MacLeod, "Factors affecting the apparent efficacy and safety of tissue plasminogen activator in thrombotic occlusion models of stroke: systematic review and meta-analysis," Journal of Cerebral Blood Flow & Metabolism, vol. 30, no. 12, pp. 1905-1913, 2010.
18. C. R. Hooijmans and M. Ritskes-Hoitinga, "Progress in using systematic reviews of animal studies to improve translational research," PLoS Medicine, vol. 10, no. 7, Article ID e1001482, 2013.
19. S. Yadav, R. Boddula, G. Genitta et al., "Prevalence & risk factors of pre-hypertension & hypertension in an affluent north Indian population," Indian Journal of Medical Research, vol. 128, no. 6, pp. 712-720, 2008.
20. G. Danaei, E. L. Ding, D. Mozaffarian et al., "The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors," PLoS Medicine, vol. 6, no. 4, Article ID e1000058, 2009.
21. World Health Organization, Global Health Risks: Mortality and Burden of Disease Attributable to Selected Major Risks, World Health Organization, Geneva, Switzerland, 2009.
22. A. V. Chobanian, G. L. Bakris, H. R. Black et al., "The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report," The Journal of the American Medical Association, vol. 289, no. 19, pp. 2560-2572, 2003.
23. S. A. Doggrell and L. Brown, "Rat models of hypertension, cardiac hypertrophy and failure," Cardiovascular Research, vol. 39, no. 1, pp. 89-105, 1998.
24. D. K. Badyal, H. Lata, and A. P. Dadhich, "Animal models of hypertension and effect of drugs," Indian Journal of Pharmacology, vol. 35, no. 6, pp. 349-362, 2003.
25. W. C. Dornas and M. E. Silva, "Animal models for the study of arterial hypertension," Journal of Biosciences, vol. 36, no. 4, pp. 731-737, 2011.
26. W. Wang, R. Liu, G. Cao et al., "A reliable rabbit model for hyperkinetic pulmonary hypertension," The Journal of Thoracic and Cardiovascular Surgery, vol. 140, no. 2, pp. 395-399, 2010.
27. F. Gross, "Experimental models of hypertension and their use in the evaluation of antihypertensive drugs," in Arterial Hypertension: The Gestation and Birth of a WHO Expert Committee Report, F. Gross and J. I. S. Robertson, Eds., pp. 198-208, G.K. Hall Medical Publishers, Boston, Mass, USA, 1980.
28. K. Okamoto and K. Aoki, "Development of a strain of spontaneously hypertensive rats," Japanese Circulation Journal, vol. 27, no. 3, pp. 282-293, 1963.
29. N. C. Trippodo and E. D. Frohlich, "Similarities of genetic (spontaneous) hypertension: man and rat," Circulation Research, vol. 48, no. 3, pp. 309-319,1981.
30. F. H. Smirk and W. H. Hall, "Inherited hypertension in rats," Nature, vol. 182, no. 4637, pp. 727-728,1958.
31. G. Bianchi, U. Fox, and E. Imbasciati, "The development of a new strain of spontaneously hypertensive rats," Life Sciences, vol. 14, no. 2, pp. 339-347, 1974.
32. L. K. Dahl, M. Heine, and L. Tassinari, "Role of genetic factors in susceptibility to experimental hypertension due to chronic excess salt ingestion," Nature, vol. 194, no. 4827, pp. 480-482, 1962.
33. N. Zamir, Y. Gutman, and D. Ben-Ishay, "Hypertension and brain catecholamine distribution in the Hebrew University Sabra, H and N rats," Clinical Science and Molecular Medicine, vol. 5, Supplement 5, 1978.
34. M. Vincent, H. Bornet, F. Berthezene, J. Dupont, and J. Sassard, "Thyroid function and blood pressure in two new strains of spontaneously hypertensive and normotensive rats," Clinical Science and Molecular Medicine, vol. 54, no. 4, pp. 391-395, 1978.
35. Y. M. Pinto, M. Paul, and D. Ganten, "Lessons from rat models of hypertension: from Goldblatt to genetic engineering," Cardiovascular Research, vol. 39, no. 1, pp. 77-88, 1998.
36. Z.-J. Sun and Z.-E. Zhang, "Historic perspectives and recent advances in major animal models of hypertension," Acta Pharmacologica Sinica, vol. 26, no. 3, pp. 295-301, 2005.
37. C. Fanelli and R. Zatz, "Linking oxidative stress, the reninangiotensin system, and hypertension," Hypertension, vol. 57, no. 3, pp. 373-374, 2011.
38. H. Goldblatt, J. Lynch, R. F. Hanzal, and W. W. Summerville, "The production of persistent elevation of systolic blood pressure by means of renal ischemia," Journal of Experimental Medicine, vol. 59, no. 3, pp. 347-379, 1934.
39. P. Zandberg, "Animal models in experimental hypertension: relevance to drug testing and discovery," in Pharmacology of Antihypertensive Drugs, P. A. van Zwieten, Ed., vol. 3 of Handbook of Hypertension, Elsevier Science, New York, NY, USA, 1984.
40. T. Sawamura and T. Nakada, "Role of dopamine in the striatum, renin-angiotensin system and renal sympathetic nerve on the development of two-kidney, one-clip goldblatt hypertension," The Journal of Urology, vol. 155, no. 3, pp. 1108-1111, 1996.
41. J. M. Flack, S. A. Atlas, J. L. Pool, and W. B. White, "Renin-angiotensin aldosterone system and hypertension: current approaches and future directions," Journal of Managed Care Pharmacy, vol. 13, no. 8, supplement, pp. S2-S32, 2007.
42. S. Moncada and A. Higgs, "The L-arginine-nitric oxide pathway," The New England Journal of Medicine, vol. 329, no. 27, pp. 2002-2012, 1993.
43. R. F. Furchgott and P. M. Vanhoutte, "Endothelium-derived relaxing and contracting factors," The FASEB Journal, vol. 3, no. 9, pp. 2007-2018, 1989.
44. M. Hermann, A. Flammer, and T. F. Lüscher, "Nitric oxide in hypertension," Journal of Clinical Hypertension, vol. 8, no. 12, supplement 4, pp. 17-29, 2006.
45. R. Rahimian, G. P. Dubé, W. Toma, N. Dos Santos, B. M. McManus, and C. van Breemen, "Raloxifene enhances nitric oxide release in rat aorta via increasing endothelial nitric oxide mRNA expression," European Journal of Pharmacology, vol. 434, no. 3, pp. 141-149, 2002.
46. J.-C. Zhong, X.-Y. Yu, Y. Huang, L.-M. Yung, C.-W. Lau, and S.-G. Lin, "Apelin modulates aortic vascular tone via endothelial nitric oxide synthase phosphorylation pathway in diabetic mice," Cardiovascular Research, vol. 74, no. 3, pp. 388-395, 2007.
47. V. Ramanathan and M. Thekkumalai, "Role of chrysin on hepatic and renal activities of Nω-nitro-L-arginine-methlyester induced hypertensive rats," International Journal of Nutrition, Pharmacology and Neurological Diseases, vol. 4, no. 1, pp. 58-63, 2014.
48. C. F. Kung, P. Moreau, H. Takase, and T. F. Luscher, "L-NAME hypertension alters endothelial and smooth muscle function in rat aorta: Prevention by trandolapril and verapamil," Hypertension, vol. 26, no. 5, pp. 744-751, 1995.
49. H. François, S. Placier, M. Flamant et al., "Prevention of renal vascular and glomerular fibrosis by epidermal growth factor receptor inhibition," The FASEB Journal,vol.18,no.7,pp.926-928, 2004.
50. P. Nyadjeu, E. P. Nguelefack-Mbuyo, A. D. Atsamo, T. B. Nguelefack, A. B. Dongmo, and A. Kamanyi, "Acute and chronic antihypertensive effects of Cinnamomum zeylanicum stem bark methanol extract in L-NAME-induced hypertensive rats," BMC Complementary and Alternative Medicine, vol. 13, article 27, 2013.
51. F. Soriguer, G. Rojo-Martínez, M. C. Dobarganesetal.,"Hypertension is related to the degradation of dietary frying oils," The American Journal of Clinical Nutrition, vol. 78, no. 6, pp.1092-1097, 2003.
52. X. F. Leong, A. Aishah, U. Nor Aini, S. Das, and K. Jaarin, "Heated palm oil causes rise in blood pressure and cardiac changes in heart muscle in experimental rats," Archives of Medical Research, vol. 39, no. 6, pp. 567-572, 2008.
53. X.-F. Leong, M. N. M. Najib, S. Das, M. R. Mustafa, and K. Jaarin, "Intake of repeatedly heated palm oil causes elevation in blood pressure with impaired vasorelaxation in rats," The Tohoku Journal of Experimental Medicine, vol. 219, no. 1, pp. 71-78, 2009.
54. X.-F. Leong, M. R. Mustafa, S. Das, and K. Jaarin, "Association of elevated blood pressure and impaired vasorelaxation in experimental Sprague-Dawley rats fed with heated vegetable oil," Lipids in Health and Disease, vol. 9, article 66, 2010.
55. K. Jaarin, M. R. Mustafa, and X.-F. Leong, "The effects of heated vegetable oils on blood pressure in rats," Clinics, vol. 66, no. 12, pp. 2125-2132, 2011.
56. X.-F. Leong, J. Salimon, M. R. Mustafa, and K. Jaarin, "Effect of repeatedly heated palm olein on blood pressure-regulating enzymes activity and lipid peroxidation in rats," Malaysian Journal of Medical Sciences, vol. 19, no. 1, pp. 20-29, 2012.
57. J. D. Gardner, G. L. Brower, T. G. Voloshenyuk, and J. S. Janicki, "Cardioprotection in female rats subjected to chronic volume overload: synergistic interaction of estrogen and phytoestrogens," American Journal of Physiology: Heart and Circulatory Physiology, vol. 294, no. 1, pp. H198-H204, 2008.
58. C. Campos, C. L. Sartorio, K. R. Casali et al., "Low-dose estrogen is as effective as high-dose treatment in rats with postmenopausal hypertension," Journal of Cardiovascular Pharmacology, vol. 63, no. 2, pp.144-151, 2014.
59. J. H. Krege, J. B. Hodgin, J. R. Hagaman, and O. Smithies, "A noninvasive computerized tail-cuff system for measuring blood pressure in mice," Hypertension, vol. 25, no. 5, pp. 1111-1115, 1995.
60. L. Yan, J. D. Zhang, B. Wang et al., "Quercetin inhibits left ventricular hypertrophy in spontaneously hypertensive rats and inhibits angiotensin II-induced H9C2 c ells hypertrophy by enhancing PPAR-γ expression and suppressing AP-1 activity," PLoS ONE, vol. 8, no. 9, Article ID e72548, 2013.
61. W. J. Welch, H. Baumgärtl, D. Lübbers, and C. S. Wilcox, "Renal oxygenation defects in the spontaneously hypertensive rat: role of AT1 receptors," Kidney International, vol. 63, no. 1, pp. 202-208, 2003.
62. C. S. Packer, "Changes in arterial smooth muscle contractility, contractile proteins, and arterial wall structure in spontaneous hypertension," Proceedings of the Society for Experimental Biology and Medicine, vol. 207, no. 2, pp. 148-174, 1994.
63. S. Klotz, I. Hay, G. Zhang, M. Maurer, J. Wang, and D. Burkhoff, "Development of heart failure in chronic hypertensive Dahl rats: focus on heart failure with preserved ejection fraction," Hypertension, vol. 47, no. 5, pp. 901-911, 2006.
64. N. Tian, R. A. Rose, S. Jordan, T. M. Dwyer, M. D. Hughson, and R. D. Manning Jr., "N-Acetylcysteine improves renal dysfunction, ameliorates kidney damage and decreases blood pressure in salt-sensitive hypertension," Journal of Hypertension, vol. 24, no. 11, pp. 2263-2270, 2006.
65. Y.-N. Cao, K. Kuwasako, J. Kato et al., "Beyond vasodilation: the antioxidant effect of adrenomedullin in Dahl salt-sensitive rat aorta," Biochemical and Biophysical Research Communications, vol. 332, no. 3, pp. 866-872, 2005.
66. J. J. Mullins, J. Peters, and D. Ganten, "Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene," Nature, vol. 344, no. 6266, pp. 541-544, 1990.
67. O. Chung, T. Schips, P. Rohmeiss, N. Gretz, M. Strauch, and T. Unger, "Protein excretion and renal adaptation of transgenic mRen2 rats to changing oral sodium loads," Journal of Hypertension, vol. 11, no. 5, pp. S188-S189, 1993.
68. Y. M. Pinto, H. Buikema, W. H. van Gilst et al., "Cardiovascular end-organ damage in Ren-2 transgenic rats compared to spontaneously hypertensive rats," Journal of Molecular Medicine, vol. 75, no. 5, pp. 371-377, 1997.
69. H. Selye, C. E. Hall, and E. M. Rowley, "Malignant hypertension produced by treatment with deoxycorticosterone acetate and sodium chloride," Canadian Medical Association Journal, vol. 49, no. 2, pp. 88-92, 1943.
70. V. Chamorro, R. Wangensteen, J. Sainz et al., "Protective effects of the angiotensin II type I (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats," Clinical Science, vol. 106, no. 3, pp. 251-259, 2004.
71. A. Iyer, V. Chan, and L. Brown, "The DOCA-salt hypertensive rat as a model of cardiovascular oxidative and inflammatory stress," Current Cardiology Reviews, vol. 6, no. 4, pp. 291-297, 2010.
72. B. Klanke, N. Cordasic, A. Hartner, R. E. Schmieder, R. Veelken, and K. F. Hilgers, "Blood pressure versus direct mineralocorticoid effects on kidney inflammation and fibrosis in DOCA-salt hypertension," Nephrology Dialysis Transplantation, vol. 23, no. 11, pp. 3456-3463, 2008.
73. J. P. Henry, Y.-Y. Liu, W. E. Nadra et al., "Psychosocial stress can induce chronic hypertension in normotensive strains of rats," Hypertension, vol. 21, no. 5, pp. 714-723, 1993.
74. A. G. Bechtold, G. Patel, G. Hochhaus, and D. A. Scheuer, "Chronic blockade of hindbrain glucocorticoid receptors reduces blood pressure responses to novel stress and attenuates adaptation to repeated stress," The American Journal of Physiology - Regulatory Integrative and Comparative Physiology, vol. 296, no. 5, pp. R1445-R1454, 2009.
75. P. A. Smith, L. N. Graham, A. F. Mackintosh, J. B. Stoker, and D. A. S. G. Mary, "Sympathetic neural mechanisms in white-coat hypertension," Journal of the American College of Cardiology, vol. 40, no. 1, pp. 126-132, 2002.
76. S. C. Coste, V. L. Brooks, D. A. McCarron, D. C. Hatton, and Y. Qi, "Captopril and stress-induced hypertension in the borderline hypertensive rat," Journal of Hypertension, vol. 13, no. 12, pp. 1391-1398, 1995.
77. Y. Nishijima, X. Zheng, H. Lund, M. Suzuki, D. L. Mattson, and D. X. Zhang, "Characterization of blood pressure and endothelial function in TRPV4-deficient mice with L-NAME- and angiotensin II-induced hypertension," Physiological Reports, vol. 2, Article ID e00199, 2014.
78. F. Xavier, A. M. F. Magalhães, and J. A. R. Gontijo, "Effect of inhibition of nitric oxide synthase on blood pressure and renal sodium handling in renal denervated rats," Brazilian Journal of Medical and Biological Research, vol. 33, no. 3, pp. 347-354, 2000.
79. H. Rauchová, O. Pecháňová, J. Kuneš, M. Vokurková, Z. Dobešová, and J. Zicha, "Chronic N-acetylcysteine administration prevents development of hypertension in Hω-nitro-L-rginine methyl ester-treated rats: the role of reactive oxygen species," Hypertension Research, vol. 28, no. 5, pp. 475-482, 2005.
80. I. Bernatova, "Endothelial dysfunction in experimental models of arterial hypertension: cause or consequence?" BioMed Research International, vol. 2014, Article ID 598271, 14 pages, 2014.
81. P. Wiesel, L. Mazzolai, J. Nussberger, and T. Pedrazzini, "Two-kidney, one clip and one-kidney, one clip hypertension in mice," Hypertension, vol. 29, no. 4, pp. 1025-1030, 1997.
82. J. Zeng, Y. Zhang, J. Mo, Z. Su, and R. Huang, "Two-kidney, two clip renovascular hypertensive rats can be used as stroke-prone rats," Stroke, vol. 29, no. 8, pp. 1708-1714, 1998.
83. H. Kiyomoto, H. Kobori, and A. Nishiyama, "Renin-angiotensin system in the kidney and oxidative stress: local renin-angiotensin-aldosterone system and NADPH oxidase-dependent oxidative stress in the kidney," in Studies on Renal Disorders, Oxidative Stress in Applied Basic Research and Clinical Practice, T. Miyata, K.-U. Eckardt, and M. Nangaku, Eds., pp. 71-91, Springer Science, Boston, Mass, USA, 2011.
84. J. Y. Moon, "Recent update of renin-angiotensin-aldosterone system in the pathogenesis of hypertension," Electrolytes & Blood Pressure, vol. 11, no. 2, pp. 41-45, 2013.
85. World Health Organization, Global Atlas on Cardiovascular Disease Prevention and Control, World Health Organization, Geneva, Switzerland, 2011.
86. G. Douglas and K. M. Channon, "The pathogenesis of atherosclerosis," Medicine, vol. 38, no. 8, pp. 397-402, 2010.
87. A. C. Ignatowski, "Influence of animal food on the organism of rabbits," Izvestia Imperatorskoi Voenno-Medicinskoi Akademii (St Petersburg), vol. 16, pp. 154-176, 1908.
88. H. Beaufrère, "Atherosclerosis: comparative pathogenesis, lipoprotein metabolism, and Avian and exotic companion mammal models," Journal of Exotic Pet Medicine, vol. 22, no. 4, pp. 320-335, 2013.
89. F. R. Kapourchali, G. Surendiran, L. Chen, E. Uitz, B. Bahadori, and M. H. Moghadasian, "Animal models of atherosclerosis," World Journal of Clinical Cases, vol. 2, no. 5, pp. 126-132, 2014.
90. P. F. Bodary and D. T. Eitzman, "Animal models of thrombosis," Current Opinion in Hematology, vol. 16, no. 5, pp. 342-346, 2009.
91. T.-F. Tzeng, H.-J. Lu, S.-S. Liou, C. J. Chang, and I.-M. Liu, "Lipid-lowering effects of zerumbone, a natural cyclic sesquiterpene of Zingiber zerumbet Smith, in high-fat diet-induced hyperlipidemic hamsters," Food and Chemical Toxicology, vol. 69, pp. 132-139, 2014.
92. M. C. Podszun, N. Grebenstein, A. Spruss et al., "Dietary α-tocopherol and atorvastatin reduce high-fat-induced lipid accumulation and down-regulate CD36 protein in the liver of guinea pigs," The Journal of Nutritional Biochemistry, vol. 25, no. 5, pp. 573-579, 2014.
93. Y. C. Haa and P. J. Barter, "Differences in plasma cholesteryl ester transfer activity in sixteen vertebrate species," Comparative Biochemistry and Physiology - Part B: Biochemistry & Molecular Biology, vol. 71, no. 2, pp. 265-269, 1982.
94. S. H. Quarfordt, B. Landis, G. Cucchiaro, Y. Yamaguchi, and B. Oswald, "Plasma cholesterol transport in anhepatic rats," Journal of Clinical Investigation, vol. 89, no. 5, pp. 1564-1570, 1992.
95. M. H. Moghadasian, J. J. Frohlich, and B. M. McManus, "Advances in experimental dyslipidemia and atherosclerosis," Laboratory Investigation, vol. 81, no. 9, pp. 1173-1183, 2001.
96. A. E. Yanni, "The laboratory rabbit: an animal model of atherosclerosis research," Laboratory Animals, vol. 38, no. 3, pp. 246-256, 2004.
97. T. Gardner and D. Johnson, "Cardiovascular system," in Experimental Surgery and Physiology: Induced Animal Models of Human Disease, M. M. Swindle and R. J. Adams, Eds., pp. 74-124, Lippincott Williams & Wilkins, Philadelphia, Pa, USA, 1988.
98. V. Fuster, J. T. Lie, L. Badimon, J. A. Rosemark, and E. J. Bowie, "Spontaneous and diet-induced coronary atherosclerosis in normal swine and swine with von Willebrand disease," Arteriosclerosis,vol.5,no.1,pp.67-73,1985.
99. F. C. White, S. M. Carroll, A. Magnet, and C. M. Bloor, "Coronary collateral development in swine after coronary artery occlusion," Circulation Research, vol. 71, no. 6, pp. 1490-1500, 1992.
100. G. Kemming, J. B. Messick, W. Mueller et al., "Can we continue research in splenectomized dogs? Mycoplasma haemocanis: old problem - new insight," European Surgical Research, vol. 36, no. 4, pp. 198-205, 2004.
101. A. L. Lock, C. A. M. Horne, D. E. Bauman, and A. M. Salter, "Butter naturally enriched in conjugated linoleic acid and vaccenic acid alters tissue fatty acids and improves the plasma lipoprotein profile in cholesterol-fed hamsters," Journal of Nutrition, vol. 135, no. 8, pp. 1934-1939, 2005.
102. S. E. Dorfman, S. Wang, S. Vega-López, M. Jauhiainen, and A. H. Lichtenstein, "Dietary fatty acids and cholesterol differentially modulate HDL cholesterol metabolism in Golden-Syrian hamsters," Journal of Nutrition, vol.135,no.3,pp.492-498,2005.
103. A. Dillard, N. R. Matthan, and A. H. Lichtenstein, "Use of hamster as a model to study diet-induced atherosclerosis," Nutrition & Metabolism, vol. 7, article 89, 2010.
104. J. C. Russell and S. D. Proctor, "Small animal models of cardiovascular disease: tools for the study of the roles of metabolic syndrome, dyslipidemia, and atherosclerosis," Cardiovascular Pathology, vol. 15, no. 6, pp. 318-330, 2006.
105. M. L. Fernandez and D. J. McNamar, "Dietary fat-mediated changes in hepatic apoprotein B/E receptor in the guinea pig: effect of polyunsaturated, monounsaturated, and saturated fat," Metabolism, vol. 38, no. 11, pp. 1094-1102, 1989.
106. T. L. Zern, K. L. West, and M. L. Fernandez, "Grape polyphenols decrease plasma triglycerides and cholesterol accumulation in the aorta of ovariectomized guinea pigs," Journal of Nutrition, vol. 133, no. 7, pp. 2268-2272, 2003.
107. M. L. Fernandez and J. S. Volek, "Guinea pigs: a suitable animal model to study lipoprotein metabolism, atherosclerosis and inflammation," Nutrition and Metabolism, vol. 3, article 17, 2006.
108. B. C. Hansen and N. L. Bodkin, "Primary prevention of diabetes mellitus by prevention of obesity in monkeys," Diabetes, vol. 42, no. 12, pp. 1809-1814,1993.
109. H. A. Barakat and R. W. St. Clair, "Characterization of plasma lipoproteins of grain- and cholesterol-fed White Carneau and Show Racer pigeons," The Journal of Lipid Research, vol. 26, no. 10, pp. 1252-1268, 1985.
110. L. C. Stout and L. W. Thorpe, "Histology of normal aortas in birds with emphasis on intimal thickening," Atherosclerosis, vol. 36, no. 4, pp. 545-558, 1980.
111. D. V. V. Dauber and L. N. N. Katz, "Experimental atherosclerosis in the chick," Archives of Pathology, vol. 36, no. 5, pp.473-492, 1943.
112. D. P. Hajjar, C. G. Fabricant, C. R. Minick, and J. Fabricant, "Virus-induced atherosclerosis. Herpesvirus infection alters aortic cholesterol metabolism and accumulation," The American Journal of Pathology, vol. 122, no. 1, pp. 62-70, 1986.
113. C. G. Fabricant and J. Fabricant, "Atherosclerosis induced by infection with Marek's disease herpesvirus in chickens," The American Heart Journal, vol. 138, no. 5, part, pp. S465-S468, 1999.
114. S. H. Zhang, R. L. Reddick, J. A. Piedrahita, and N. Maeda, "Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E," Science, vol. 258, no. 5081, pp. 468-471, 1992.
115. S. Ishibashi, M. S. Brown, J. L. Goldstein, R. D. Gerard, R. E. Hammer, and J. Herz, "Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery," The Journal of Clinical Investigation, vol. 92, no. 2, pp. 883-893, 1993.
116. A. Rigotti, B. L. Trigatti, M. Penman, H. Rayburn, J. Herz, and M. Krieger, "A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism," Proceedings of the National Academy of Sciences of the United States of America, vol. 94, no. 23, pp. 12610-12615, 1997.
117. J. Buchanan, P. K. Mazumder, P. Hu et al., "Reduced cardiac efficiency and altered substrate metabolism precedes the onset of hyperglycemia and contractile dysfunction in two mouse models of insulin resistance and obesity," Endocrinology, vol. 146, no. 12, pp. 5341-5349, 2005.
118. B. Winters, Z. Mo, E. Brooks-Asplund et al., "Reduction of obesity, as induced by leptin, reverses endothelial dysfunction in obese (Lepob) mice," Journal of Applied Physiology, vol. 89, no. 6, pp. 2382-2390, 2000.
119. L. M. Zucker and H. N. Antoniades, "Insulin and obesity in the Zucker genetically obese rat "fatty"," Endocrinology, vol. 90, no. 5, pp. 1320-1330, 1972.
120. Z. Zak, T. Gautier, L. Dumont et al., "Effect of cholesteryl ester transfer protein (CETP) expression on diet-induced hyperlipidemias in transgenic rats," Atherosclerosis, vol. 178, no. 2, pp. 279-286, 2005.
121. P. J. Dolphin, "Serum and hepatic nascent lipoproteins in normal and hypercholesterolemic rats," Journal of Lipid Research, vol. 22, no. 6, pp. 971-989, 1981.
122. X. Li, Y. Liu, H. Zhang, L. Ren, Q. Li, and N. Li, "Animal models for the atherosclerosis research: a review," Protein and Cell,vol. 2, no. 3, pp. 189-201, 2011.
123. J. Pang, Q. Xu, X. Xu et al., "Hexarelin suppresses high lipid diet and vitamin D3-induced atherosclerosis in the rat," Peptides, vol. 31, no. 4, pp. 630-638, 2010.
124. Y. Okada, K. Yamaguchi, T. Nakajima et al., "Rosuvastatin ameliorates high-fat and high-cholesterol diet-induced nonalcoholic steatohepatitis in rats," Liver International, vol. 33, no. 2, pp. 301-311, 2013.
125. A. H. Lichtman, S. K. Clinton, K. Iiyama, P. W. Connelly, P. Libby, and M. I. Cybulsky, "Hyperlipidemia and atherosclerotic lesion development in LDL receptor-deficient mice fed defined semipurified diets with and without cholate," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 19, no. 8, pp. 1938-1944, 1999.
126. M. T. Quinn, S. Parthasarathy, L. G. Fong, and D. Steinberg, "Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis," Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 9, pp. 2995-2998, 1987.
127. S. R. J. Maxwell and G. Y. H. Lip, "Free radicals and antioxidants in cardiovascular disease," British Journal of Clinical Pharmacology, vol. 44, no. 4, pp. 307-317, 1997.
128. I. Staprãns, J. H. Rapp, X.-M. Pan, D. A. Hardman, and K. R. Feingold, "Oxidized lipids in the diet accelerate the development of fatty streaks in cholesterol-fed rabbits," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 16, no. 4, pp. 533-538, 1996.
129. I. Staprans, X.-M. Pan, J. H. Rapp, C. Grunfeld, and K. R. Feingold, "Oxidized cholesterol in the diet accelerates the development of atherosclerosis in LDL receptor- and apolipoprotein E-deficient mice," Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 20, no. 3, pp. 708-714, 2000.
130. S. K. Adam, S. Das, I. N. Soelaiman, N. A. Umar, and K. Jaarin, "Consumption of repeatedly heated soy oil increases the serum parameters related to atherosclerosis in Ovariectomized rats," The Tohoku Journal of Experimental Medicine, vol. 215, no. 3, pp. 219-226, 2008.
131. S. K. Adam, I. N. Soelaiman, N. A. Umar, N. Mokhtar, N. Mohamed, and K. Jaarin, "Effects of repeatedly heated palm oil on serum lipid profile, lipid peroxidation and homocysteine levels in a post-menopausal rat model," McGill Journal of Medicine, vol. 11, no. 2, pp. 145-151, 2008.
132. S. K. Adam, S. Das, and K. Jaarin, "A detailed microscopic study of the changes in the aorta of experimental model of postmenopausal rats fed with repeatedly heated palm oil," International Journal of Experimental Pathology, vol. 90, no. 3, pp. 321-327, 2009.
133. W. B. Kannel and P. W. F. Wilson, "Risk factors that attenuate the female coronary disease advantage," Archives of Internal Medicine, vol. 155, no. 1, pp. 57-61, 1995.
134. T. K. Xian, N. A. Omar, L. W. Ying et al., "Reheated palm oil consumption and risk of atherosclerosis: evidence at ultrastructural level," Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 828170, 6 pages, 2012.
135. C.-Y. Ng, Y. Kamisah, O. Faizah, and K. Jaarin, "The role of repeatedly heated soybean oil in the development of hypertension in rats: association with vascular inflammation," International Journal of Experimental Pathology, vol. 93, no. 5, pp. 377-387, 2012.